| A Study in Subjects With Retinitis Pigmentosa (NCT05392179) | Aldeyra Therapeutics, Inc. | 2022-07-14 |
| Natural History of PRPF31 Mutation-Associated Retinal Dystrophy (NCT05573984) | PYC Therapeutics | 2022-07-07 |
| Dose Escalation Study to Evaluate the Safety/Tolerability and Efficacy of EA-2353 in Subjects With Retinitis Pigmentosa (NCT05392751) | Endogena Therapeutics, Inc | 2022-06-02 |
| Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for NAION (NCT05147701) | The Foundation for Orthopaedics and Regenerative Medicine | 2022-02-01 |
| Study to Assess the Safety and Efficacy of OCU400 for Retinitis Pigmentosa and Leber Congenital Amaurosis (NCT05203939) | Ocugen | 2022-01-24 |
| The Perceptual Experience of Argus II Users (NCT05285618) | University of California, Santa Barbara | 2022-01-11 |
| Study to Evaluate the Efficacy Safety and Tolerability of QR-421a in Subjects With RP Due to Mutations in Exon 13 of the USH2A Gene With Early to Moderate Vision Loss (Celeste) (NCT05176717) | Laboratoires Thea | 2021-12-15 |
| Longitudinal Study of a Bionic Eye (NCT05158049) | Center for Eye Research Australia | 2021-12-09 |
| Study to Evaluate the Efficacy Safety and Tolerability of Ultevursen in Subjects With RP Due to Mutations in Exon 13 of the USH2A Gene (Sirius) (NCT05158296) | Laboratoires Thea | 2021-12-08 |
| Structural and Functional Characterization of Rare Ocular Diseases (NCT05258032) | Barcelona Macula Foundation | 2021-11-24 |
| An Open-Label Extension Study to Evaluate Safety & Tolerability of QR-421a in Subjects With Retinitis Pigmentosa (NCT05085964) | Laboratoires Thea | 2021-09-16 |
| Retrospective NIS to Evaluate the Patient Benefit of TES (NCT04983914) | Okuvision GmbH | 2021-09-06 |
| Adaptive Optics Imaging of Outer Retinal Diseases (NCT05355415) | Food and Drug Administration (FDA) | 2021-08-27 |
| CNS10-NPC for the Treatment of RP (NCT04284293) | Cedars-Sinai Medical Center | 2021-07-22 |
| Efficacy and Safety of MCO-010 Optogenetic Therapy in Adults With Retinitis Pigmentosa [RESTORE] (NCT04945772) | Nanoscope Therapeutics Inc. | 2021-07-13 |
| Rate of Progression of PCDH15-Related Retinal Degeneration in Usher Syndrome 1F (NCT04765345) | Jaeb Center for Health Research | 2021-06-08 |
| Phase 1 Study of Intravitreal Autologous CD34+ Stem Cell Therapy for Retinitis Pigmentosa (NCT04925687) | University of California, Davis | 2021-06-01 |
| Safety and Efficacy of Subretinal Transplantation of Clinical Human Embryonic Stem Cell Derived Retinal Pigment Epitheliums in Treatment of Retinitis Pigmentosa (NCT03944239) | Qi Zhou | 2021-05-19 |
| Effects of Treatment With N- Acetylcysteine on Visual Outcomes in Patients With Retinitis Pigmentosa (NCT04864496) | Shahid Beheshti University of Medical Sciences | 2021-04-17 |
| Study of BEST1 Vitelliform Macular Dystrophy (NCT05809635) | Columbia University | 2021-03-30 |
| Environmental Localization Mapping and Guidance for Visual Prosthesis Users (NCT04359108) | Johns Hopkins University | 2021-03-16 |
| Natural History Study of Retinitis Pigmentosa Type 11 (NCT04805658) | Oslo University Hospital | 2021-02-01 |
| CB-PRP in Retinitis Pigmentosa and Dry Age-related Macular Degeneration (NCT04636853) | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 2020-12-23 |
| Safety of Repeat Intravitreal Injection of Human Retinal Progenitor Cells (jCell) in Adult Subjects With Retinitis Pigmentosa (NCT04604899) | jCyte, Inc | 2020-12-01 |
| A Natural History Study to Evaluate Functional and Anatomical Progression in Retinitis Pigmentosa (NCT04558983) | Johns Hopkins University | 2020-06-11 |
| Rate of Progression in EYS Related Retinal Degeneration (NCT04127006) | Jaeb Center for Health Research | 2020-02-25 |
| Oral Hydroxychloroquine (HCQ) for Retinitis Pigmentosa Caused by P23H- Rhodopsin (RHO) (NCT04120883) | University of Michigan | 2020-02-25 |
| Prospective Natural History Study of Retinitis Pigmentosa (NCT04285398) | SparingVision | 2020-02-12 |
| BS01 in Patients With Retinitis Pigmentosa (NCT04278131) | Bionic Sight LLC | 2020-02-06 |
| NR600 System Retinal Prosthesis for Patients With Retinal Degenerative Diseases (NCT04295304) | Nano Retina | 2020-01-17 |
| A New Treatment of Retinitis Pigmentosa (NCT03998384) | Aier School of Ophthalmology, Central South University | 2020-01-01 |
| Advancing Understanding of Transportation Options (NCT04141891) | University of Colorado, Denver | 2019-12-12 |
| Dose-Escalation Study to Evaluate the Safety and Tolerability of Intravitreal vMCO-I in Patients With Advanced Retinitis Pigmentosa (NCT04919473) | Nanoscope Therapeutics Inc. | 2019-10-23 |
| Spheroidal Mesenchymal Stem Cells in Retinitis Pigmentosa (NCT05712148) | Acibadem University | 2019-10-11 |
| Validation of Standardized Test Protocols to Assess the Impact of Visual Pathologies in Daily Life Activities (NCT04448860) | Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts | 2019-10-04 |
| Bimodal and Coaxial High Resolution Ophtalmic Imaging (NCT04620876) | Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts | 2019-10-01 |
| Retinitis Pigmentosa Clinical Measures and Repeatability Testing of Potential Outcome Measures (NCT03845218) | National Eye Institute (NEI) | 2019-09-27 |
| PDE6A Gene Therapy for Retinitis Pigmentosa (NCT04611503) | STZ eyetrial | 2019-09-24 |
| Minocycline Treatment in Retinitis Pigmentosa (NCT04068207) | Sun Yat-sen University | 2019-08-25 |
| Interventional Study of Implantation of hESC-derived RPE in Patients With RP Due to Monogenic Mutation (NCT03963154) | Centre d'Etude des Cellules Souches | 2019-08-19 |
| High Resolution, High-speed Multimodal Ophthalmic Imaging (NCT04129021) | Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts | 2019-07-03 |
| FIGHT-RP 1 Extension Study (NCT03999021) | Johns Hopkins University | 2019-06-24 |
| Management of Retinitis Pigmentosa by Mesenchymal Stem Cells by Wharton's Jelly Derived Mesenchymal Stem Cells (NCT04224207) | Ankara Universitesi Teknokent | 2019-04-01 |
| Prospective Open Clinical and Genetic Study of Patients With Retinitis Pigmentosa (NCT03901391) | Sensor Technology for Deafblind | 2019-03-26 |
| Study to Evaluate Safety and Tolerability of QR-421a in Subjects With RP Due to Mutations in Exon 13 of the USH2A Gene (NCT03780257) | ProQR Therapeutics | 2019-03-06 |
| PMCF Study for Partial Vision Restoration Using the Subretinal Implant RETINA IMPLANT Alpha AMS (NCT02588430) | Retina Implant AG | 2019-03-01 |
| Characterizing Rate of Progression in USHer Syndrome (CRUSH) Study (NCT04820244) | Radboud University Medical Center | 2019-02-11 |
| Management of Retinitis Pigmentosa Via Combination of Wharton's Jelly-derived Mesenchymal Stem Cells and Magnovision (NCT05800301) | Ankara Universitesi Teknokent | 2019-01-01 |
| Stem Cells Therapy in Degenerative Diseases of the Retina (NCT03772938) | Pomeranian Medical University Szczecin | 2018-12-13 |
| Argus II Retinal Prosthesis System - Better Vision RP Study (NCT03418116) | Second Sight Medical Products | 2018-11-01 |
| Safety Issues of Peribulbar Injection of UC-MSC in Patients With Retinitis Pigmentosa (NCT04315025) | PT. Prodia Stem Cell Indonesia | 2018-10-07 |
| Development of Visual Function Evaluation Method (2) (NCT03626207) | Astellas Pharma Inc | 2018-10-04 |
| Visual Performance Measures in a Virtual Reality Environment for Assessing Clinical Trial Outcomes in Those With Severely Reduced Vision (NCT04281732) | Queen's University, Belfast | 2018-10-01 |
| The Effects of Cannabis on Visual Functions in Healthy and Retinitis Pigmentosa Patients (NCT03078309) | Hadassah Medical Organization | 2018-09-01 |
| A First-in-human, Proof of Concept Study of CPK850 in Patients With RLBP1 Retinitis Pigmentosa (NCT03374657) | Novartis Pharmaceuticals | 2018-08-22 |
| Pupil Dynamics and Color Vision for the Detection of Eye Diseases (NCT04909398) | Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts | 2018-03-22 |
| Exercise and RP (AVAMC and Emory) (NCT03381235) | Emory University | 2018-02-23 |
| Computer-Assisted Rehabilitation Environment Training After Argus Retinal Prosthesis (NCT03444961) | The Cleveland Clinic | 2018-01-30 |
| Collision Warning Device for Blind and Visually Impaired (NCT03057496) | Massachusetts Eye and Ear Infirmary | 2018-01-22 |
| High Resolution Retina Imaging (NCT04128150) | Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts | 2018-01-17 |
| Management of Cystoid Macular Edema Secondary to Retinitis Pigmentosa Via Subliminal Micropulse Yellow Laser (NCT04234438) | Ankara Universitesi Teknokent | 2018-01-01 |
| Natural History Study of Patients With X-linked Retinal Dystrophy Associated With Mutations in Retinitis Pigmentosa GTPase Regulator (RPGR) (NCT03349242) | MeiraGTx UK II Ltd | 2017-12-19 |
| Safety and Efficacy Study in Patients With Retinitis Pigmentosa Due to Mutations in PDE6B Gene (NCT03328130) | eyeDNA Therapeutics | 2017-11-06 |
| Development of Visual Function Evaluation Method (NCT03281005) | Astellas Pharma Inc | 2017-11-01 |
| Experimental and Clinical Studies of Retinal Stimulation (NCT03635645) | University of Michigan | 2017-10-30 |
| Argus II/ORCAM Device Study (NCT03248388) | Mayo Clinic | 2017-08-31 |
| Object Finder for a Retinal Prosthesis (NCT04319809) | Minnesota HealthSolutions | 2017-07-01 |
| Clinical and Genetic Testing of Patients With Usher Syndrome (NCT03319524) | Sensor Technology for Deafblind | 2017-05-17 |
| Observational Natural History Study of Autosomal Dominant Retinitis Pigmentosa (adRP) (NCT02926092) | Shire | 2017-03-13 |
| Safety and Efficacy of Intravitreal Injection of Human Retinal Progenitor Cells in Adults With Retinitis Pigmentosa (NCT03073733) | jCyte, Inc | 2017-03-01 |
| The FIGHT-RP1 Study (NCT03063021) | Johns Hopkins University | 2017-02-15 |
| Management of Retinitis Pigmentosa Via Electromagnetic Stimulation and Platelet Rich Plasma (NCT04252534) | Ankara Universitesi Teknokent | 2017-01-01 |
| Effects of Subtenon-injected Autologous Platelet-rich Plasma on Visual Functions in Eyes With Retinitis Pigmentosa (NCT04238858) | Ankara Universitesi Teknokent | 2016-09-01 |
| Studying a Potential Protective Effect of L-Dopa on Retinitis Pigmentosa (NCT02837640) | Beirut Eye Specialist Hospital | 2016-06-01 |
| AUgmented REality for the Visually Impaired - Part 1 (NCT02614651) | Centre Hospitalier Universitaire de Nīmes | 2016-05-01 |
| Rod and Cone Mediated Function in Retinal Disease (NCT02617966) | National Eye Institute (NEI) | 2016-03-24 |
| Aflibercept for Macular Oedema With Underlying Retinitis Pigmentosa (AMOUR) Study (NCT02661711) | Moorfields Eye Hospital NHS Foundation Trust | 2016-03-01 |
| Stem Cell Ophthalmology Treatment Study II (NCT03011541) | MD Stem Cells | 2016-01-01 |
| Compensation for Blindness With the Intelligent Retinal Implant System (IRIS V2) in Patients With Retinal Dystrophy (NCT02670980) | Science Corporation | 2016-01-01 |
| Safety and Tolerability of hRPC in Retinitis Pigmentosa (NCT02464436) | ReNeuron Limited | 2015-12-01 |
| Clinical Implication of Retinitis Pigmentosa Molecular Diagnostic Using High Throughput Sequencing. (NCT02860520) | University Hospital, Strasbourg, France | 2015-11-03 |
| Visual Activity Evoked by Infrared in Humans After Dark Adaptation (NCT02909985) | University of New Mexico | 2015-09-01 |
| Nerve Growth Factor Eye Drops Treatment in Patients With Retinitis Pigmentosa and Cystoid Macular Edema (NCT02609165) | Ospedale San Raffaele | 2015-05-01 |
| Identifying Genes and Mutations Underlying Retinitis Pigmentosa and Allied Diseases (NCT02309866) | Hillel Yaffe Medical Center | 2015-01-01 |
| Post-Market Study of the Argus® II Retinal Prosthesis System - France (NCT02303288) | Second Sight Medical Products | 2014-11-20 |
| Sildenafil for Treatment of Choroidal Ischemia (NCT04356716) | Columbia University | 2014-11-11 |
| Cone Rescue in Retinitis Pigmentosa by the Treatment of Lycium Barbarum (NCT02244996) | The Hong Kong Polytechnic University | 2014-11-01 |
| Clinical Study to Evaluate Safety and Efficacy of BMMNC in Retinitis Pigmentosa (NCT01914913) | Chaitanya Hospital, Pune | 2014-09-01 |
| Electro-acupuncture and Transcorneal Electrical Stimulation (TES) for Retinitis Pigmentosa (NCT02086890) | Nova Southeastern University | 2014-08-13 |
| Inherited Retinal Degenerative Disease Registry (NCT02435940) | Foundation Fighting Blindness | 2014-06-01 |
| Study of Oral Minocycline in Treating Bilateral Cystoid Macular Edema Associated With Retinitis Pigmentosa (NCT02140164) | National Eye Institute (NEI) | 2014-05-01 |
| Observational Study of the Argus® II Retinal Prosthesis System (NCT01999049) | University Health Network, Toronto | 2014-04-01 |
| Intravitreal Injection of SeeQ CdSe 655 Alt Nanoparticles for Patients With Degenerative Retinal Diseases (NCT04008771) | 2C Tech Corp | 2014-01-06 |
| New Enrollment Post-Approval Study of the Argus® II Retinal Prosthesis System (NCT01860092) | Second Sight Medical Products | 2014-01-01 |
| A Dose Ranging Study to Evaluate the Safety and Potential Efficacy of rhNGF in Patients With Retinitis Pigmentosa (RP) (NCT02110225) | Dompé Farmaceutici S.p.A | 2014-01-01 |
| Evaluation of Objective Perimetry Using Chromatic Multifocal Pupillometer (NCT02014389) | Sheba Medical Center | 2013-12-01 |
| Biomarkers In Retinitis Pigmentosa (BIRP) (NCT01949623) | Johns Hopkins University | 2013-09-01 |
| High Resolution Retinal Imaging (NCT01866371) | University of Pennsylvania | 2013-05-01 |
| Restoring Vision With the Intelligent Retinal Implant System (IRIS V1)in Patients With Retinal Dystrophy (NCT01864486) | Science Corporation | 2013-04-01 |
| TES for the Treatment of RP (NCT01847365) | University of Oxford | 2013-04-01 |